#Chronic Hepatitis Cohort Study

The level of fibrosis among people with hep C strongly predicts their risk of developing serious liver disease or dying within five years.

Relying solely on a liver biopsy to diagnose cirrhosis among people with hepatitis C likely misses three in four cases of the advanced stage o...

Antiviral treatment for hepatitis B is linked to a reduced risk of hepatocellular carcinoma, the most common form of liver cancer.

Only one in five deaths of people with hepatitis C receives a listing of the virus on the death certificate.

People with hepatitis C virus die 15 years earlier and have a 12-times greater risk of death when compared with those without the virus.

A large study has underscored that the hepatitis B and C viruses disproportionately affect baby boomers.